Patients with #breastcancer who did not achieve a pCR had better survival with adjuvant chemotherapy than with neoadjuvant chemotherapy. https://bit.ly/49utroi #bcsm

An #oncology social worker describes 3 nature-focused strategies — forest bathing, horticultural therapy, and animal-assisted therapy — that can help patients with #cancer. https://bit.ly/44d5oXt #CancerCare #ecotherapy

Screening for neurologic paraneoplastic syndromes among patients with #SCLC remains low in the United States. Presented at #JADPRO25. https://bit.ly/3LA6juD #lcsm #LungCancerAwarenessMonth #LCAM

A better understanding of the symptom clusters experienced by patients with #multipleMyeloma can help nurses develop interventions that are targeted to reducing those symptoms and can reduce the patient’s overall symptom burden. From @oncologynurseadv.bsky.social.#multipleMyeloma https://bit.ly/49NDJQt

SustainabilityPlanning markedly enhances the longevity and effectiveness of patient navigation programs. From #AONN2025 https://bit.ly/488Cv0X #cancerCare

Glofitamab may induce a complete response rate in 27% of real-world cases of R/R #DLBCL. Published in @ash.hematology.org journal @bloodjournals.hematology.org and @hematologyadvisor.bsky.social.#DLBCL https://bit.ly/3WQaW6k #lymsm #lymphoma

In patients with high-risk #MIBC, the 2-year locoregional failure-free survival rate was 87.1% with radiotherapy and 76.0% with observation. From @cancertherapyadv.bsky.social.#MIBC https://bit.ly/499ZqtR #blcsm #bladdercancer

In triple-negative #breastcancer, pembrolizumab at a tenth of the current standard dose, plus chemotherapy, increased pathologic pCR compared to chemotherapy alone. Presented at #ESMO25, covered by @cancertherapyadv.bsky.social.#breastcancer#ESMO25 https://bit.ly/4hUF1vb #TNBC #bcsm

Few LGBTQ+ cancer survivors received tailored survivorship care plans and other specialized resources even though their SOGI was known to the care team. Published in @jamanetworkopen.com and @cancertherapyadv.bsky.social. https://bit.ly/4r1bV1s #LGBTQCancer #LGBTOnc

A recent study identified cognitive traits that may be associated with greater risk of #alcohol use disorder but also highlighted context-dependent features associated with this risk. From @jamapsychiatry.com.#alcohol https://bit.ly/4nQelwW #AUD

Patients with newly diagnosed #multipleMyeloma experience a high symptom burden before and after chemotherapy. Precise management of symptoms at multiple stages of treatment are essential. https://bit.ly/4qFPyyc #myeloma

MRD-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk #CLL. Published in @bloodjournals.hematology.org and @rarediseaseadvisor.bsky.social.#CLL https://bit.ly/4hSzzJ9 #leusm #lymsm

Adding nimotuzumab to post-surgery adjuvant cisplatin-based chemoradiotherapy does not improve survival outcomes in patients with #HNSCC. Presented at #ESMO25. https://bit.ly/47oCYMb #hncsm #headandneckcancer

Electroacupuncture to the Ciliao, Zhongliao, and Xialiao acupoints significantly accelerates time to urinary continence after radical prostatectomy for #prostatecancer, a new study finds. https://bit.ly/4hI1yLF #pcsm #gucsm

Antibody-drug conjugates sharing the same type of payload reportedly also share #adverseEvents in common, but with some differences in patterns associated with AEs. https://bit.ly/43dNlQx

Researchers constructed a risk stratification model for moderate-to-severe CRF based on information derived from an AI model. Specifically, they focused on the impact of CRF on the well-being of patients with #colorectalcancer. https://bit.ly/4ooSON5 #crcsm

The use of rule out #melanoma terminology on pathology requisitions has a low positive predictive value for the diagnosis of melanoma. Published in @dermatologyadvisor.bsky.social.#melanoma https://bit.ly/4oHtCRr #melcsm #skcsm

The @fda.gov has approved Zepzelca® in combo with Tecentriq® or Tecentriq Hybreza® for the maintenance treatment of adult patients with ES-#SCLC. From @medicalprofref.bsky.social.#SCLC https://bit.ly/4hyXqxt #lcsm #lungcancer

Although #prostatecancer is one of the most common types of cancer, inequalities in treatment services often exist. https://bit.ly/47AgpDj #pcsm

Adding anthracyclines to adjuvant taxane-based chemotherapy may reduce recurrence risk for patients with HR+/HER2- #breastcancer with a high genomic risk score. Published in @cancertherapyadv.bsky.social.#breastcancer https://bit.ly/4oGibtm #bcsm #BCAM #BreastCancerAwarenessMonth

#Healthcare workers are exposed to hazardous #chemotherapy drugs such as cyclophosphamide and 5-fluorouracil, which can cause harm to them. Presented at #ESMO25. https://bit.ly/47kNBhZ #cancerdrugs

A MCED blood test increased the number of screen-detected #cancers more than 7-fold when added to the USPSTF A/B recommended screening. Presented during #ESMO25. https://bit.ly/3Jp6nwz #cancerdetection

Adding pembrolizumab to weekly paclitaxel, with or without bevacizumab, improved PFS in patients with platinum-resistant, recurrent #ovariancancer in a phase 3 trial. From @cancertherapyadv.bsky.social.#ovariancancer https://bit.ly/3JoJ3yW #gyncsm

For patients with advanced or metastatic #RCC, fruquintinib plus sintilimab is associated with improved PFS compared to investigator’s choice of axilitinib or everolimus. Presented at #ESMO25, covered by @cancertherapyadv.bsky.social.#RCC#ESMO25 https://bit.ly/3WKELVI

#Telehealth interventions have potential to improve QOL in women with #breastcancer, according to a recent study, which also pointed to a need for further research to clarify outcomes. https://bit.ly/4qjJdIA #bcsm #BCAM #BreastCancerAwarenessMonth #ESMO25

Holistic, nurse-led discussions about sexuality can profoundly enhance quality of life for women surviving #gynecologicCancer, according to a qualitative study exploring lived experiences after treatment. https://bit.ly/3L4T30Q #gyncsm #ESMO25

#ChatGPT can serve as a valuable adjunct in the #oncology setting — as a supportive and planning tool that can be especially helpful for common complications such as febrile neutropenia. https://bit.ly/3JfT5T5 #oncnurse #ESMO25

For patients with advanced or metastatic #renalCellCarcinoma, fruquintinib plus sintilimab is associated with improved PFS compared to investigator’s choice of axilitinib or everolimus. From @cancertherapyadv.bsky.social.#renalCellCarcinoma https://bit.ly/3WKELVI #RCC

In fit older patients with advanced #biliarytractcancer, the combination chemotherapeutic regimen of GEM+CDDP+S-1 is associated with longer PFS compared with that of GEM+CDDP. Published in @gastroadvisor.bsky.social.#biliarytractcancer https://bit.ly/3KW5UlP

Researchers characterized patterns and causes for inadequate nutritional intake in pediatric patients with #cancer in a study conducted in Brazil. https://bit.ly/43cxsd0 #pediatricCancer #oncnurse

Taller height may explain a “substantial proportion” of the excess #cancerrisk observed in men, according to researchers. Reported in @cancertherapyadv.bsky.social.#cancerrisk https://bit.ly/4nRxfV1

In this new column, @breastcancerorg.bsky.social explores the unsaid messages patients with #breastcancer get from their oncology nurses. https://bit.ly/4715UtH #bcsm #BCAM #BreastCancerAwarenessMonth

“Robust #survivorship care is important because #cancer patients have a unique set of medical needs,” said Melissa Erickson, MD. From @cancertherapyadv.bsky.social.#survivorship#cancer https://bit.ly/3VS71p2

A strategic investment in the upskilling and certification of #medicalAssistants in the ambulatory #oncology clinic supports a modern model of team-based care. https://bit.ly/48jkq0K #OncNurse

A 100% success rate was achieved with regards to the adequate harvesting of CD34+ cells among a cohort of patients who underwent remobilization with EAP, with or without plerixafor. From @hematologyadvisor.bsky.social. https://bit.ly/46xOHYv

ALST-based evaluation may be an effective diagnostic tool for patients with acute #leukemia. Published in @ascopost.bsky.social JCO Global Oncology. https://bit.ly/3KAa7eV #leusm

Overweight and obesity are associated with improved overall survival among patients with metastatic #prostatecancer. Published in @endocrinologyadv.bsky.social.#prostatecancer https://bit.ly/475trt9 #pcsm

IFN-α nasal spray reduces the incidence of #COVID19 infection by approximately 40% in patients with #cancer without increasing adverse events compared with placebo. Published in @infectiousdisease.bsky.social.#COVID19#cancer https://bit.ly/4nGjDf1 #COVID19nCancer

#Rhabdomyosarcoma in children younger than 2 years is associated with significant challenges in terms of local recurrence rates and survival outcomes. https://bit.ly/471oUqJ

Positive mental health literacy significantly improved job well-being among #palliativecare nurses, with job crafting acting as a partial mediator in this relationship. https://bit.ly/4mD6rGt

Topline data were announced from a phase 3 trial evaluating pirtobrutinib in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma without 17p deletions. https://bit.ly/48Jk4k3 #lymsm

A 100% success rate was achieved with regards to the adequate harvesting of CD34+ cells among a cohort of patients who underwent remobilization with EAP, with or without plerixafor. From @hematologyadvisor.bsky.social. https://bit.ly/46xOHYv

Immunotherapy-based combinations demonstrated meaningful survival benefits and favorable safety in real-world Brazilian patients with unresectable or metastatic #hepatocellularCarcinoma. Published in @ascopost.bsky.social and @rarediseaseadvisor.bsky.social#hepatocellularCarcinoma https://bit.ly/3KPgQS9 #HCC

Overweight and obesity are associated with improved overall survival among patients with metastatic #prostatecancer. Published in @endocrinologyadv.bsky.social.#prostatecancer https://bit.ly/475trt9 #pcsm

Positive mental health literacy significantly improved job well-being among #palliative care nurses, with job crafting acting as a partial mediator in this relationship. https://bit.ly/4mD6rGt

The use of a #stressball during port #catheter needle insertion significantly reduced perceived stress and pain while increasing patient satisfaction. https://bit.ly/4gJWkOM

Single men with #cancer reported feeling overlooked by their HCPs. https://bit.ly/488azL9

"The @fda.gov has granted Breakthrough Therapy designation to Rina-S for the treatment of adults with recurrent or progressive #endometrialcancer..." From @medicalprofref.bsky.social.#endometrialcancer https://bit.ly/4noIi82 #gyncsm

A majority of #cancerdrugs approved in the US during 2019-2022 had “clinical trial uncertainties” that arose from “issues related to trial design, conduct, analysis, or reporting … about drug efficacy and safety” . From @jama.com and @cancertherapyadv.bsky.social.#cancerdrugs https://bit.ly/48rqpAE

Nilotinib was associated with greater odds of a molecular response compared with imatinib among patients with Ph+ CML. Published in @cureusmedical.bsky.social and @hematologyadvisor.bsky.social. https://bit.ly/47Y8dyy #leusm